4553 — Towa Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥136bn
- ¥302bn
- ¥209bn
- 44
- 73
- 95
- 86
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 18,886 | 20,709 | 18,728 | 22,246 | 4,605 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -2,056 | -3,862 | 2,526 | -2,350 | 1,914 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -6,169 | -5,966 | -19,325 | -8,721 | -23,383 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 19,001 | 19,166 | 12,354 | 22,129 | 2,545 |
Capital Expenditures | -11,354 | -4,670 | -9,879 | -13,576 | -30,469 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 7,360 | -34,871 | 779 | -46,153 | 185 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3,994 | -39,541 | -9,100 | -59,729 | -30,284 |
Financing Cash Flow Items | -1 | -1 | -29 | -26 | -156 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -809 | 11,748 | 184 | 46,540 | 17,481 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 15,141 | -7,938 | 4,199 | 9,915 | -8,573 |